Clinical trial
Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
NCT00242177 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00242177 |
|---|---|
| Title | Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability |
| Official title | Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability |
| Lead sponsor | University of Illinois at Chicago, Other |
| Collaborators | Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Relapsing-Remitting |
| Intervention type | Drug |
| Interventions | ACTOS (Pioglitazone) |
| Enrollment | 30 |
| Start date | Oct 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Oct 19, 2005 |
| Last update posted | Jul 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: